Scarica l'app Stockscreener
2.19
3.52%
-0.08
Dopo l'orario di chiusura:
2.27
0.08
+3.65%
Conduit Pharmaceuticals Inc Borsa (CDT) Ultime notizie
How Conduit Pharmaceuticals Inc. stock performs during market volatilityFree Stock Index Interpretation - Newser
Why Conduit Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Market Real-Time Monitoring - beatles.ru
What makes Conduit Pharmaceuticals Inc. stock price move sharplyGrowth Optimized Stock Radar - Newser
Why Conduit Pharmaceuticals Inc. Equity Warrant stock attracts strong analyst attentionFree Day Trading Recommendations - Newser
What makes Conduit Pharmaceuticals Inc. Equity Warrant stock price move sharplyVolume Spike Monitors - Newser
How Conduit Pharmaceuticals Inc. Equity Warrant stock performs during market volatilityFree Predictions - Newser
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy - Bluefield Daily Telegraph
First Nasdaq Pharma Company Explores Bitcoin Reserves While Advancing Drug Development - Stock Titan
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries - FinancialContent
AI Breakthrough: Conduit Pharma Files 4 Game-Changing Patents for Novel Drug Combinations - Stock Titan
Conduit Pharmaceuticals (NASDAQ:CDT) Shares Down 4.2% – Should You Sell? - Defense World
Conduit Pharmaceuticals (NASDAQ:CDT) Stock Price Down 0.4% – What’s Next? - Defense World
Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 - MENAFN.com
Conduit Pharmaceuticals Enters Development Agreement With Manoira To Test Drugs In Animals: Retail Sees Stock Above $10 By Stocktwits - Investing.com India
Conduit Pharmaceuticals enters joint development agreement with Manoira - TipRanks
Conduit Pharma Expands Drug Pipeline to $15B Animal Health Market Through Zero-Cost Development Deal - Stock Titan
Conduit Pharmaceuticals Sets 2025 Annual Meeting Date - TipRanks
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
CDT stock plunges to 52-week low, hitting $3.21 amid steep decline By Investing.com - Investing.com South Africa
CDT stock plunges to 52-week low, hitting $3.21 amid steep decline - Investing.com India
Conduit Pharmaceuticals regains Nasdaq compliance - MSN
Conduit Pharmaceuticals receives approval for Nasdaq listing - MSN
Conduit Pharmaceuticals approved to transfer listing to Nasdaq Capital Market - TipRanks
Conduit Pharmaceuticals moves to Nasdaq Capital Market By Investing.com - Investing.com India
Conduit Pharma Gains Nasdaq Capital Market Approval, Transfer Effective May 23 - Nasdaq
Conduit Pharmaceuticals moves to Nasdaq Capital Market - Investing.com Australia
Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market - The Manila Times
Biotech Rising Star Conduit Pharmaceuticals Gets Green Light for Nasdaq Capital Market Transfer - Stock Titan
Conduit Pharmaceuticals meets Nasdaq listing standards By Investing.com - Investing.com South Africa
Conduit Pharmaceuticals meets Nasdaq listing standards - Investing.com Australia
Conduit Pharmaceuticals Regains Compliance With Nasdaq's Bid Price, Equity Requirements - marketscreener.com
Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance - The Manila Times
Conduit Pharmaceuticals Inc. Regains Compliance with Nasdaq Listing Requirements - Nasdaq
Upcoming Stock Splits This Week (May 19 to May 23) – Stay Invested - The Globe and Mail
Conduit Pharma Stock Drops On Reverse Stock Split Announcement: Retail’s Pessimistic - MSN
3.40%
2.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):